Tuberculosis and Respiratory Diseases

  • 제62권4호
  • /
  • Pages.284-289
  • /
  • 2007
  • /
  • 1738-3536(pISSN)
  • /
  • 2005-6184(eISSN)
대한결핵및호흡기학회 (The Korean Academy of Tuberculosis and Respiratory Diseases)
권호 표지

폐암과 상부소화호흡기암이 동반된 환자의 경우 임상적 특징

Clinical Features of Patients with Lung Cancer and Upper Aerodigestive Tract Cancer

  • 이창률 (연세대학교 의과대학 내과학교실) ;
  • 정재희 (연세대학교 의과대학 내과학교실) ;
  • 장윤수 (연세대학교 의과대학 내과학교실) ;
  • 김세규 (연세대학교 의과대학 내과학교실) ;
  • 김형중 (연세대학교 의과대학 내과학교실) ;
  • 장준 (연세대학교 의과대학 내과학교실) ;
  • 김성규 (연세대학교 의과대학 내과학교실) ;
  • 안철민 (연세대학교 의과대학 내과학교실)
  • Lee, Chang Youl (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Chung, Jae Hee (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Chang, Yoon Soo (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Kim, Se Kyu (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Kim, Hyung Jung (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Chang, Joon (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Kim, Sung Kyu (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Ahn, Chul Min (Department of Internal Medicine, Yonsei University College of Medicine)
  • 투고 : 2007.02.08
  • 심사 : 2007.03.26
  • 발행 : 2007.04.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

연구배경: 상부소화호흡기암과 폐암의 연관관계가 있다는 것은 알려져 있지만 국내 임상발현 양상에 대한 보고는 부족한 상황이다. 이에 저자들은 폐암과 상부소화호흡기암이 동반된 경우 환자들이 어떠한 조직학적 유형과 임상경과를 보이는지 알고자 하였다. 방법: 1992년 1월부터 2005년 12월까지 13년동안 연세대학교 의과대학 영동세브란스병원에서 진단된 상부소화호흡기암과 폐암이 진단된 20예를 대상으로 후향적으로 조직학적 유형과 임상 양상을 조사하였다. 결과: 1) 13년 동안 연세대학교 의과대학 영동세브란스병원에서 상부소화호흡기암과 폐암이 진단된 20예 중 남자 19예, 여자 1예로 평균연령은 58.45세, 흡연자는 14예, 평균 흡연량은 46갑년이었다. 폐암과 상부소화호흡기암의 발생 순서에서 상부소화호흡기암 발생 후 폐암의 발생은 12예, 폐암 발생 후 상부소화호흡기암의 발생은 5예이었다. 2) 폐암과 상부소화호흡기암의 조직학적 차이를 확인해 볼 수 있었던 5예에서 면역 조직 화학 염색을 통해 조직학적으로 동일한 경우 3예, 다르다고 여겨진 경우가 2예에서 관찰되었다. 상부소화호흡기암 진단 후 폐암이 진단되는 기간은 평균 36.8개월이고 폐암 진단 후 상부소화호흡기암 진단이 되는 기간은 16.2개월이었다. 3) 상부소화호흡기암 진단 후 폐암이 진단된 경우 폐암의 치료로 수술을 시행한 예는 없으며 항암제치료 2예, 항암제치료와 방사선 치료 병행은 4예이었고 나마지 경우는 환자의 불량한 전신상태와 치료거부 등으로 보전적 치료를 행하였다. 결론: 폐암과 상부소화호흡계 암의 발생의 기원이 동일한 경우와 독립적으로 발생하는 경우 모두 가능한 것으로 여겨지며 상부소화호흡기암 환자에게 조기에 폐암을 진단 할 수 있도록 진찰 시 적극적으로 주기적인 저선량 흉부 전산화단층촬영을 시행하는 것이 의미가 있을 것으로 사료된다.

Background: To define the clinical features of patients with lung and upper aerodigestive tract cancer through a review of the histopathology, clinical features and follow-up results. Methods: Patients with lung and upper aerodigestive tract cancer who were diagnosed in Young dong Severance Hospital from 1992 to 2005, were retrospectively reviewed. The clinical data, radiologic findings, pathologic findings, treatment modalities were evaluated. Result: There was a total of 20 patients with aerodigestive tract cancer who were diagnosed with lung cancer over a 13 years period. The mean age was $58.45{\pm}15.09$ years and 19 cases were male. There were 14 smokers with an average pack year of 46 years. Twelve patients had aerodigestive tract cancer and later developed lung cancer, and 5 lung cancer patients were later diagnosed with aerodigestive tract cancer. Conclusion: These results suggest that cancers of the aerodigestive tract and lung can arise as either dependent or independent events and most aerodigestive tract cancer patients who developed lung cancer are not treated properly. Therefore, regular low dose chest CT with close suspicion is needed to properly manage upper aerodigestive tract cancer patients.

키워드

참고문헌

  1. X wu YH, Lippman SM, ed. Upper aerodigestive tract cancers. Philadelphia: Lippincott Williams & Wilkins; 1999
  2. Schwager K, Nebel A, Baier G, Hoppe F. [Second primary carcinomas in the upper aerodigestive tract in different locations and age groups]. Laryngorhinootologie 2000;79:599-603 https://doi.org/10.1055/s-2000-7675
  3. Gao X, Fisher SG, Mohideen N, Emami B. Second primary cancers in patients with laryngeal cancer: a population-based study. Int J Radiat Oncol Biol Phys 2003;56:427-35 https://doi.org/10.1016/S0360-3016(02)04613-8
  4. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med 1993; 328:184-94 https://doi.org/10.1056/NEJM199301213280306
  5. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 1953;6:963-8 https://doi.org/10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q
  6. Strong MS, Incze J, Vaughan CW. Field cancerization in the aerodigestive tract--its etiology, manifestation, and significance. J Otolaryngol 1984;13:1-6
  7. Hemminki K, Boffetta P. Multiple primary cancers as clues to environmental and heritable causes of cancer and mechanisms of carcinogenesis. IARC Sci Publ 2004;(157):289-97
  8. Spitz MR, Hoque A, Trizna Z, Schantz SP, Amos CI, King TM, et al. Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract. J Natl Cancer Inst 1994;86:1681-4 https://doi.org/10.1093/jnci/86.22.1681
  9. Ha PK, Califano JA. The molecular biology of mucosal field cancerization of the head and neck. Crit Rev Oral Biol Med 2003;14:363-9 https://doi.org/10.1177/154411130301400506
  10. Ministry of Health Welfare. 2005 Annual report of the Korea Central Cancer Registry. Gwacheon: Ministry of Health Welfare Republic of Korea; 2005
  11. Marioni G, Marchese-Ragona R, Cartei G, Marchese F, Staffieri A. Current opinion in diagnosis and treatment of laryngeal carcinoma. Cancer Treat Rev 2006;32:504-15 https://doi.org/10.1016/j.ctrv.2006.07.002
  12. Chan AT, Teo PM, Johnson PJ. Nasopharyngeal carcinoma. Ann Oncol 2002;13:1007-15 https://doi.org/10.1093/annonc/mdf179
  13. Dhooge IJ, De Vos M, Van Cauwenberge PB. Multiple primary malignant tumors in patients with head and neck cancer: results of a prospective study and future perspectives. Laryngoscope 1998;108:250-6 https://doi.org/10.1097/00005537-199802000-00017
  14. Geurts TW, Nederlof PM, van den Brekel MW, van't Veer LJ, de Jong D, Hart AA, et al. Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: metastasis or second primary? Clin Cancer Res 2005;11:6608-14 https://doi.org/10.1158/1078-0432.CCR-05-0257
  15. Ogden GR. Second malignant tumours in head and neck cancer. BMJ 1991;302:193-4 https://doi.org/10.1136/bmj.302.6770.193
  16. Muir C, Weiland L. Upper aerodigestive tract cancers. Cancer 1995;75:S147-53 https://doi.org/10.1002/1097-0142(19950101)75:1+<147::AID-CNCR2820751304>3.0.CO;2-U
  17. Lippman SM, Hong WK. Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys 1989;17:691-4 https://doi.org/10.1016/0360-3016(89)90126-0
  18. Carey TE. Field cancerization: are multiple primary cancers monoclonal or polyclonal? Ann Med 1996; 28:183-8 https://doi.org/10.3109/07853899609033118
  19. Chung KY, Mukhopadhyay T, Kim J, Casson A, Ro JY, Goepfert H, et al. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res 1993;53:1676-83
  20. Bedi GC, Westra WH, Gabrielson E, Koch W, Sidransky D. Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res 1996;56:2484-7
  21. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996;56:2488-92
  22. Califano J, Westra WH, Meininger G, Corio R, Koch WM, Sidransky D. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin Cancer Res 2000;6:347-52
  23. Engelen AM, Stalpers LJ, Manni JJ, Ruijs JH, van Daal WA. Yearly chest radiography in the early detection of lung cancer following laryngeal cancer. Eur Arch Otorhinolaryngol 1992;249:364-9 https://doi.org/10.1007/BF00192255
  24. Fontana RS, Sanderson DR, Taylor WF, Woolner LB, Miller WE, Muhm JR, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study. Am Rev Respir Dis 1984;130:561-5
  25. Rachmat L, Vreeburg GC, de Vries N, Hordijk GJ, Lubsen H, Manni JJ, et al. The value of twice yearly bronchoscopy in the work-up and follow-up of patients with laryngeal cancer. Eur J Cancer 1993;29A:1096-9